Our flow cytometry analysis of tumor-infiltrating immune cells from TMPyP4-treated mice revealed an increase in the frequencies of CD45+, CD3+, CD8+ T cells, and DCs (Fig. 3j–m, q–t). This evidence concerns the gene PTPRC and neoplasm.